SCHEMBL3200134

SCHEMBL3200134

CCOc1cc(C(N)c2cccnc2)ccc1OC(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALPL P05186 1/20 0.40
PDE4B Q07343 5/20 0.39
PDE4D Q08499 3/20 0.39
PDE4A P27815 2/20 0.39
PDE4C Q08493 1/20 0.39
MAPT P10636 2/20 0.38
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
DHFR P00374 1/20 0.36
POLB P06746 2/20 0.36
PDPK1 O15530 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129614 0.86 PDE4B (0.40) KDM4EALDH1A1MAPK1NPSR1PDE4B
SCHEMBL3126024 0.86 PDE4D (0.43) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL3127976 0.84 PDE4D (0.56) PDE4BPDE4DPDE4APDE4C
SCHEMBL3123524 0.84 PDE4D (0.49) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL3129210 0.84 PDE4D (0.43) SLC6A2SLC6A4KDM4EALDH1A1MAPK1
SCHEMBL3131252 0.83 ATM (0.41) KDM4EMAPK1NPSR1ALPLPDE4B
SCHEMBL3130706 0.79 AAK1 (0.39) KDM4EMAPK1NPSR1PDE4BPDE4D
SCHEMBL3201429 0.75 PDE4B (0.38) KDM4EALDH1A1MAPK1NPSR1PDE4B
SCHEMBL3117907 0.75 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMAPK1NPSR1
SCHEMBL3122742 0.75 L3MBTL1 (0.50) SLC6A2SLC6A4KDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B SLC6A2 1188/4885SLC6A4 254/4885KDM4E 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.